Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedNov 17, 2021Acetaminophen Oral SuspensioncGMP Deviations: Product manufactured with contaminated raw ingredient.Precision Dose Inc. · D-0094-2022Class ITerminatedNov 10, 2021CubicinPresence of Particulate Matter: Identified as Glass ParticlesMerck Sharp & Dohme Corp · D-0093-2022Class ICompletedNov 10, 2021Methocarbamol 500mg TabletLabeling: Label Error on Declared Strength; Bottles labeled as Methocarbamol 500 mg Tablets actually contain Methocarbamol 750 mg TabletsBryant Ranch Prepack, Inc. dba BRP Pharmaceuticals · D-0092-2022Class IITerminatedNov 10, 2021Irbesartan and Hydrochlorothiazide Tablets USPCGMP Deviations: impurity N-nitrosoirbesartan detected in APILupin Pharmaceuticals Inc. · D-0090-2022Class IITerminatedNov 10, 2021Irbesartan and Hydrochlorothiazide Tablets USPCGMP Deviations: impurity N-nitrosoirbesartan detected in APILupin Pharmaceuticals Inc. · D-0089-2022Class IITerminatedNov 10, 2021Irbesartan Tablets USPCGMP Deviations: impurity N-nitrosoirbesartan detected in APILupin Pharmaceuticals Inc. · D-0088-2022Class IITerminatedNov 10, 2021Irbesartan Tablets USPCGMP Deviations: impurity N-nitrosoirbesartan detected in APILupin Pharmaceuticals Inc. · D-0087-2022Class IITerminatedNov 10, 2021Irbesartan Tablets USPCGMP Deviations: impurity N-nitrosoirbesartan detected in APILupin Pharmaceuticals Inc. · D-0086-2022Class IITerminatedNov 10, 2021Dr. Reddy's Ezetimibe and Simvastatin TabletsFailed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and...Dr. Reddy's Laboratories, Inc. · D-0085-2022Class IITerminatedNov 10, 2021Dr. Reddy's Ezetimibe and Simvastatin TabletsFailed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivityDr. Reddy's Laboratories, Inc. · D-0084-2022Class IITerminatedNov 10, 2021Dr. Reddy's Ezetimibe and Simvastatin TabletsFailed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivityDr. Reddy's Laboratories, Inc. · D-0083-2022Class IITerminatedNov 10, 2021Dr. Reddy's Ezetimibe and Simvastatin TabletsFailed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivityDr. Reddy's Laboratories, Inc. · D-0082-2022Class IITerminatedNov 10, 2021Dr. Reddy's Ezetimibe and Simvastatin TabletsFailed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivityDr. Reddy's Laboratories, Inc. · D-0081-2022Class IIITerminatedNov 3, 2021Gatifloxacin Ophthalmic SolutionFailed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.Lupin Pharmaceuticals Inc. · D-0091-2022Class IIITerminatedNov 3, 2021Rizatriptan Benzoate Orally Disintegrating Tablets 10mgOut-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.Macleods Pharma USA, Inc · D-0080-2022Class IIITerminatedNov 3, 2021Rizatriptan Benzoate Orally Disintegrating Tablets 5mgOut-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.Macleods Pharma USA, Inc · D-0079-2022Class IIITerminatedNov 3, 2021Rizatriptan Benzoate Film Coated TabletsOut-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.Macleods Pharma USA, Inc · D-0078-2022Class IIITerminatedNov 3, 2021Afassco Pain Free Plus X-STRENGTH PAIN RELIEVERFailed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.Ultra Seal Corporation · D-0077-2022Class IIITerminatedNov 3, 2021Xpect First aid Extra Strength PAIN AWAYFailed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.Ultra Seal Corporation · D-0076-2022Class IIITerminatedNov 3, 2021Advance Formula Pain RelieverFailed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.Ultra Seal Corporation · D-0075-2022Class IIITerminatedNov 3, 2021North by Honeywell PAIN STOPPER EXTRA STRENGTHFailed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.Ultra Seal Corporation · D-0074-2022Class IIITerminatedNov 3, 2021AERO Tab PAIN RELIEVERFailed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.Ultra Seal Corporation · D-0073-2022Class IIITerminatedNov 3, 2021ZEE+ painaid ESF Extra-Strength FormulaFailed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.Ultra Seal Corporation · D-0072-2022Class IIITerminatedNov 3, 2021Vica-Cet BACK PAIN RELIEFFailed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.Ultra Seal Corporation · D-0071-2022Class IIITerminatedNov 3, 2021PainAway IIFailed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.Ultra Seal Corporation · D-0070-2022Class IIITerminatedNov 3, 2021AllerClear D-24 hrFailed Moisture LimitsSun Pharmaceutical Industries Inc · D-0069-2022Class IIITerminatedNov 3, 2021Loratadine-D Extended-Release TabletsFailed Moisture LimitsSun Pharmaceutical Industries Inc · D-0068-2022Class IITerminatedNov 3, 2021SODIUM SELINITE 200MCG/ML FOR INJLack of Assurance of Sterility: FDA inspection raised sterility assurance concernsFirst Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · D-0067-2022Class IITerminatedNov 3, 2021PROGESTERONE 100MG/ML MDV OIL INJECTIONLack of Assurance of Sterility: FDA inspection raised sterility assurance concernsFirst Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · D-0066-2022Class IITerminatedNov 3, 2021MIT/B12 25/50/50MG/ML 1MG/ML MDVLack of Assurance of Sterility: FDA inspection raised sterility assurance concernsFirst Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · D-0065-2022Class IITerminatedNov 3, 2021MIC/B12A/B6 15/50/100 5MG/50MG/ML MDVLack of Assurance of Sterility: FDA inspection raised sterility assurance concernsFirst Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · D-0064-2022Class IITerminatedNov 3, 2021MIC/B12A 25/50/50MG/ML 1MG/ML MDVLack of Assurance of Sterility: FDA inspection raised sterility assurance concernsFirst Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · D-0063-2022Class IITerminatedNov 3, 2021MIC 25/50/50MG/ML MDVLack of Assurance of Sterility: FDA inspection raised sterility assurance concernsFirst Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · D-0062-2022Class IITerminatedNov 3, 2021METHYLCOBALAMIN 5000MCG/ML MDV INJLack of Assurance of Sterility: FDA inspection raised sterility assurance concernsFirst Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · D-0061-2022Class IITerminatedNov 3, 2021METHYLCOBALAMIN 12.5MG/ML MDV INJ SOLNLack of Assurance of Sterility: FDA inspection raised sterility assurance concernsFirst Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · D-0060-2022Class IITerminatedNov 3, 2021METHYLCOBALAMIN 1000MCG/ML MDV INJLack of Assurance of Sterility: FDA inspection raised sterility assurance concernsFirst Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · D-0059-2022Class IITerminatedNov 3, 2021METHYLCOBALAMIN 10Lack of Assurance of Sterility: FDA inspection raised sterility assurance concernsFirst Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · D-0058-2022Class IITerminatedNov 3, 2021FOLIC ACID 10MG/ML MDV INJLack of Assurance of Sterility: FDA inspection raised sterility assurance concernsFirst Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · D-0057-2022Class IITerminatedNov 3, 2021CALCIUM GLUCONATE 10% INJLack of Assurance of Sterility: FDA inspection raised sterility assurance concernsFirst Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · D-0056-2022Class IITerminatedNov 3, 2021BENZALKONIUM CHLORIDE 0.013% SOLUTIONLack of Assurance of Sterility: FDA inspection raised sterility assurance concernsFirst Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · D-0055-2022